Creates "New Jersey Kratom Consumer Protection Act."
Impact
The legislation imposes strict regulations on kratom retailers, including prohibitions on selling products to individuals under the age of 21, with significant penalties for violations. For instance, retailers found in breach of sales regulations face civil penalties that escalate with repeated offenses, leading to potential criminal charges for third violations. The Department of Health is responsible for enforcing these regulations and is authorized to establish necessary standards for product safety, as well as testing protocols to assess the health implications of kratom products on consumers.
Summary
Senate Bill S1384, titled the New Jersey Kratom Consumer Protection Act, seeks to establish regulations regarding the sale and distribution of kratom products throughout the state. The bill defines 'kratom' as the plant Mitragyna speciosa, known for its stimulant and opioid-like properties, and establishes criteria for labeling, selling, and distributing kratom products to ensure consumer safety. Notably, the act mandates that products must be labeled appropriately and include information about their content, specifically the amounts of potentially concerning alkaloids.
Contention
This bill has generated discussions regarding both public health safety and the operational impacts on kratom retailers. Proponents argue that consumer protection is paramount given the opioid properties of kratom and the potential for health risks. Opponents, however, may raise concerns about the bill being overly restrictive on a legal product, arguing that such regulation can negatively impact consumer access to kratom, particularly for individuals who use it for legitimate medicinal purposes. As a result, the legislation balances a push for increased consumer safety with the economic activities of kratom retailers.
Controlled substances: other; sentencing guidelines for retail sale of products containing ephedrine or pseudoephedrine; modify. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4947'25
Criminal procedure: sentencing guidelines; sentencing guidelines for illicit use of xylazine; provide for. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m).
Criminal procedure: sentencing guidelines; sentencing guidelines for delivering, manufacturing, or possessing with intent to deliver certain controlled substances; amend. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4255'25
Criminal procedure: sentencing guidelines; sentencing guidelines for delivering, manufacturing, or possessing with intent to deliver heroin or fentanyl; amend. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: SB 0430'25
Criminal procedure: sentencing guidelines; sentencing guidelines for manufacturing, creating, delivering, or possessing with intent certain schedule 1 and 2 controlled substances; amend. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: SB 460'25